Hepatocrinology: New Conceptual Frameworks Linking Endocrine Disorders to Chronic Liver Pathology
Journal of Gastrointestinal and Liver Diseases · 2026
DOI: 10.15403/jgld-6940 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Gastrointestinal and Liver Diseases, 2026. Verfasst von Codruța-Claudia Gherman-Lencu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology-Fundamental Discipline 1st Department, FAMMS, "Iuliu Hațieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania. codruta_lmc@…. Hauptthemen laut MEDLINE: Liver, Endocrine System Diseases, Liver Diseases, Endocrine System. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Hepatocrinology is an emerging interdisciplinary field that examines the bidirectional interactions between the liver and the endocrine system, emphasizing how hepatic dysfunction influences hormonal regulation and how endocrine disorders, in turn, shape liver metabolism, inflammation, and disease progression. This review summarizes current theoretical frameworks, including hepato-endocrine axes, hepatokine signaling, and multi-organ communication models, highlighting the liver’s role as a central endocrine hub. Key hepatic hormones, transport proteins, and hepatokines such as fetuin-A, fibroblast growth factor 21, and selenoprotein P are discussed in relation to metabolic disorders including metabolic dysfunction-associated steatotic liver disease, metabolic dysfunction-associated steatohepatitis, polycystic ovary syndrome, diabetes, and advanced chronic liver disease. The review further explores hormonal axes involving the thyroid, pancreas, adrenal glands, parathyroids, and gonads, illustrating their complex interplay with hepatic physiology. Current challenges, such as limited long-term studies and therapeutic controversies, are examined alongside emerging directions involving hepatokine-targeted therapies, precision medicine, and microbiome-driven modulation. Understanding these interconnected pathways is essential for improving diagnostic accuracy, risk stratification, and therapeutic strategies in hepato-endocrine disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Endocrinology-Fundamental Discipline 1st Department, FAMMS, "Iuliu Hațieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania. codruta_lmc@yahoo.com.
- Department of Pneumology, Clinical Hospital "Leon Daniello" Cluj-Napoca, Romania. marinabudgeanina99@gmail.com.
- Department of Internal Medicine, "Iuliu Hațieganu" University of Medicine and Pharmacy, Cluj Napoca; CF Clinical Hospital Cluj-Napoca, Romania. albmirela@yahoo.ro.
- Department of Haematology, Prof. Dr. Ioan Chiricuta The Oncology Institute, Cluj-Napoca, Romania. madalinabancos@yahoo.com.
- Nursing-Fundamental Discipline 1st Department, FAMMS, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania. lilidavid2007@yahoo.com.
- Department of Internal Medicine, "Iuliu Hațieganu" University of Medicine and Pharmacy, Cluj Napoca; CF Clinical Hospital Cluj-Napoca, Romania. teodora.alexescu@gmail.com.
Zitieren
APA
Gherman-Lencu, C. C., Bud, M. G., Perne, M. G., Gavris, M. D., David, L. E., & Alexescu, T. G. (2026). Hepatocrinology: New Conceptual Frameworks Linking Endocrine Disorders to Chronic Liver Pathology. Journal of Gastrointestinal and Liver Diseases. https://doi.org/10.15403/jgld-6940
Vancouver
Gherman-Lencu CC, Bud MG, Perne MG, Gavris MD, David LE, Alexescu TG. Hepatocrinology: New Conceptual Frameworks Linking Endocrine Disorders to Chronic Liver Pathology. Journal of Gastrointestinal and Liver Diseases. 2026. doi:10.15403/jgld-6940
BibTeX
@article{GhermanLencu2026,
author = {Gherman-Lencu, Codruța-Claudia and Bud, Marina-Geanina and Perne, Mirela-Georgiana and Gavris, Mădălina-Daiana and David, Liliana-Elisabeta and Alexescu, Teodora-Gabriela},
title = {Hepatocrinology: New Conceptual Frameworks Linking Endocrine Disorders to Chronic Liver Pathology},
journal = {Journal of Gastrointestinal and Liver Diseases},
year = {2026},
doi = {10.15403/jgld-6940}
}
EUVIMED